Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121818333 | 12181833 | 3 | F | 201603 | 20160809 | 20160315 | 20160817 | EXP | US-ASTRAZENECA-2016SE25446 | ASTRAZENECA | 824.00 | MON | F | Y | 131.50000 | KG | 20160817 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121818333 | 12181833 | 1 | PS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | 204760 | 25 | MG | TABLET | QD | |||||||
| 121818333 | 12181833 | 2 | SS | MOVANTIK | NALOXEGOL OXALATE | 1 | Oral | 204760 | 25 | MG | TABLET | QD | |||||||
| 121818333 | 12181833 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 121818333 | 12181833 | 4 | C | SAVELLA | MILNACIPRAN HYDROCHLORIDE | 1 | Oral | 0 | 150 | MG | BID | ||||||||
| 121818333 | 12181833 | 5 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 4.0MG AS REQUIRED | 0 | 4 | MG | ||||||||
| 121818333 | 12181833 | 6 | C | METHENAMINE HIPP TAB | 2 | Oral | 0 | 1 | G | TABLET | BID | ||||||||
| 121818333 | 12181833 | 7 | C | CELCOXIB | 2 | Oral | 0 | 200 | MG | QD | |||||||||
| 121818333 | 12181833 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | BIW | ||||||||||
| 121818333 | 12181833 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 80 | MG | BID | ||||||||
| 121818333 | 12181833 | 10 | C | METOLACONE | 2 | Oral | 0 | 5 | MG | BID | |||||||||
| 121818333 | 12181833 | 11 | C | AMITIZA | LUBIPROSTONE | 1 | Oral | TWO TIMES A DAY | 0 | ||||||||||
| 121818333 | 12181833 | 12 | C | LINZESS | LINACLOTIDE | 1 | Oral | 0 | 290 | UG | QD | ||||||||
| 121818333 | 12181833 | 13 | C | FETCIMA | 2 | Oral | 0 | 80 | MG | QD | |||||||||
| 121818333 | 12181833 | 14 | C | XANAX | ALPRAZOLAM | 1 | Oral | 2.0MG AS REQUIRED | 0 | 2 | MG | ||||||||
| 121818333 | 12181833 | 15 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 800.0MG AS REQUIRED | 0 | 800 | MG | ||||||||
| 121818333 | 12181833 | 16 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 121818333 | 12181833 | 17 | C | 3 VITAMIN COMPOUND | 2 | Oral | 1 DAILY | 0 | |||||||||||
| 121818333 | 12181833 | 18 | C | CENTRUM SILVER VITAMIN | 2 | Oral | 1 DAILY | 0 | |||||||||||
| 121818333 | 12181833 | 19 | C | HYDROCODONE | HYDROCODONE | 1 | 10/325MG 1 EVERY SIX HOURS AS NEEDED FOR PAIN IN KNEES FROM FALLS | 0 | |||||||||||
| 121818333 | 12181833 | 20 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | TWO TIMES A DAY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121818333 | 12181833 | 1 | Bowel movement irregularity |
| 121818333 | 12181833 | 2 | Constipation |
| 121818333 | 12181833 | 3 | Hiatus hernia |
| 121818333 | 12181833 | 4 | Blood pressure abnormal |
| 121818333 | 12181833 | 5 | Nausea |
| 121818333 | 12181833 | 6 | Infection |
| 121818333 | 12181833 | 7 | Rheumatoid arthritis |
| 121818333 | 12181833 | 8 | Vitamin D decreased |
| 121818333 | 12181833 | 9 | Oedema peripheral |
| 121818333 | 12181833 | 10 | Fibromyalgia |
| 121818333 | 12181833 | 11 | Gastrointestinal disorder |
| 121818333 | 12181833 | 12 | Abdominal discomfort |
| 121818333 | 12181833 | 13 | Ill-defined disorder |
| 121818333 | 12181833 | 14 | Panic attack |
| 121818333 | 12181833 | 15 | Fibromyalgia |
| 121818333 | 12181833 | 16 | Blood cholesterol abnormal |
| 121818333 | 12181833 | 17 | Hypovitaminosis |
| 121818333 | 12181833 | 18 | Asthenia |
| 121818333 | 12181833 | 20 | Hiatus hernia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121818333 | 12181833 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121818333 | 12181833 | Arthralgia | |
| 121818333 | 12181833 | Confusional state | |
| 121818333 | 12181833 | Fall | |
| 121818333 | 12181833 | Fear of falling | |
| 121818333 | 12181833 | Gait disturbance | |
| 121818333 | 12181833 | Hiatus hernia | |
| 121818333 | 12181833 | Incontinence | |
| 121818333 | 12181833 | Inflammation | |
| 121818333 | 12181833 | Infrequent bowel movements | |
| 121818333 | 12181833 | Nausea | |
| 121818333 | 12181833 | Neoplasm malignant | |
| 121818333 | 12181833 | Product use issue | |
| 121818333 | 12181833 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121818333 | 12181833 | 1 | 201510 | 0 | ||
| 121818333 | 12181833 | 2 | 201510 | 0 | ||
| 121818333 | 12181833 | 18 | 201603 | 0 |